Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C1GO
|
||||
Former ID |
DNC014199
|
||||
Drug Name |
SC-558
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530753] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H11BrF3N3O2S
|
||||
Canonical SMILES |
C1=CC(=CC=C1C2=CN(N=C2C(F)(F)F)C3=CC=C(C=C3)S(=O)(=O)N)<br />Br
|
||||
InChI |
1S/C16H11BrF3N3O2S/c17-11-3-1-10(2-4-11)14-9-23(22-15(14)16(18,19)20)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25)
|
||||
InChIKey |
HWAPFDFOIKEYLL-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [530753] | |
KEGG Pathway | Arachidonic acid metabolism | ||||
Metabolic pathways | |||||
NF-kappa B signaling pathway | |||||
VEGF signaling pathway | |||||
TNF signaling pathway | |||||
Retrograde endocannabinoid signaling | |||||
Serotonergic synapse | |||||
Ovarian steroidogenesis | |||||
Oxytocin signaling pathway | |||||
Regulation of lipolysis in adipocytes | |||||
Leishmaniasis | |||||
Pathways in cancer | |||||
Chemical carcinogenesis | |||||
MicroRNAs in cancer | |||||
Small cell lung cancer | |||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.